Performance of molecular methods for identification of unusual subtypes of hepatitis C virus genotype 2

Pierina D’Angelo, Rossana Celeste Jaspe, Carmen Luisa Loureiro, Cristina Gutiérrez, María Zulay Sulbarán, Yoneira Sulbarán, Felix Toro, Flor Helene Pujol, .

Keywords: Hepatitis C/genetics, genotype, pathology, molecular

Abstract

Introduction: Hepatitis C virus (HCV) displays high genetic variability, with seven genotypes and numerous subtypes. The determination of the viral type has been essential for the selection and timing of antiviral treatment. In Venezuela, HCV genotype 2 is relatively diverse, being particularly prevalent subtype 2j.
Objective: To evaluate the performance of methodologies for genotyping HCV, particularly for identification of subtype 2j.
Materials and methods: HCV genotype and subtype were determined by reverse hybridization technique (LiPA) and sequencing of the HCV 5’UTR and NS5B regions.
Results: A total of 65 samples from HCV-infected patients were analyzed. PCR amplifications of the 5’UTR region exhibited the highest sensitivity (100% vs 91% for LiPA and 77% for NS5B). Genotype determination, taking as reference test NS5B, showed 100% concordance with the other methods, and 67% and 59% for subtypes with 5´NC and LiPA, respectively. NS5B sequencing allowed the identification of subtypes 2j and 2s, which were not detected by the other methods. A specific LiPA pattern was not
observed for HCV subtype 2j.
Conclusion: Although being the methodology with lowest sensitivity for amplification of HCV RNA, sequencing NS5B region remains a powerful tool for correct discrimination of the different HCV subtypes, which is of epidemiological relevance.

Downloads

Download data is not yet available.
  • Pierina D’Angelo Laboratorio de Programas Especiales-Hepatitis y SIDA, Instituto Nacional de Higiene “Rafael Rangel”, Caracas, Venezuela
  • Rossana Celeste Jaspe Laboratorio de Virología Molecular, Instituto Venezolano de Investigaciones Científicas, Caracas, Venezuela
  • Carmen Luisa Loureiro Laboratorio de Virología Molecular, Instituto Venezolano de Investigaciones Científicas, Caracas, Venezuela
  • Cristina Gutiérrez Laboratorio de Programas Especiales-Hepatitis y SIDA, Instituto Nacional de Higiene “Rafael Rangel”, Caracas, Venezuela
  • María Zulay Sulbarán Laboratorio de Virología, Postgrado en Biología Aplicada, Universidad de Oriente, Núcleo Sucre, Cumaná, Venezuela
  • Yoneira Sulbarán Laboratorio de Virología Molecular, Instituto Venezolano de Investigaciones Científicas, Caracas, Venezuela
  • Felix Toro Instituto de Inmunología, Universidad Central de Venezuela, Caracas, Venezuela
  • Flor Helene Pujol Laboratorio de Virología Molecular, Instituto Venezolano de Investigaciones Científicas, Caracas, Venezuela

References

Lanini S, Easterbrook PJ, Zumla A, Ippolito G. Hepatitis C: Global epidemiology and strategies for control. Clin Microbiol Infect. 2016;22:833-8. https://doi.org/10.1016/j.cmi.2016.07.035

Simmonds P. Genetic diversity and evolution of hepatitis C virus - 15 years on. J Gen Virol. 2004;85:3173-88. https://doi.org/10.1099/vir.0.80401-0

Hnatyszyn HJ. Chronic hepatitis C and genotyping: The clinical significance of determining HCV genotypes. Antivir Ther. 2005;10:1-11.

Tellinghuisen TL, Evans MJ, von Hahn T, You S, Rice CM. Studying hepatitis C virus: Making the best of a bad virus. J Virol. 2007;81:8853-67. https://doi.org/10.1128/JVI.00753-07

Smith DB, Bukh J, Kuiken C, Muerhoff AS, Rice CM, Stapleton JT. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource. Hepatology. 2014;59:318-27. https://doi.org/10.1002/hep.26744

Timm J, Roggendorf M. Sequence diversity of hepatitis C virus: Implications for immune control and therapy. World J Gastroenterol. 2007;13:4808-17. https://doi.org/10.3748/wjg.v13.i36.4808

Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014;61:S45-57.

https://doi.org/10.1016/j.jhep.2014.07.027

Polaris Observatory HCV Collaborators. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: A modelling study. Lancet Gastroenterol Hepatol. 2017;2:161-76. https://doi.org/10.1016/S2468-1253(16)30181-30189

Alvarado-Mora MV, Pinho JR. Epidemiological update of hepatitis B, C and Delta in Latin America. Antivir Ther. 2013;18:429-33. https://doi.org/10.3851/IMP2595

Sulbarán MZ, Di Lello FA, Sulbarán Y, Cosson C, Loureiro CL, Rangel HR, et al. Genetic history of hepatitis C virus in Venezuela: High diversity and long time of evolution of HCV genotype 2. PLoS One. 2010;5:e14315. https://doi.org/10.1371/journal.pone.0014315

Cristina J. Genetic diversity and evolution of hepatitis C virus in the Latin American region. J Clin Virol. 2005;34(Suppl.2):S1-7. https://doi.org/10.1016/S1386-6532(05)00393-8

Cuypers L, Ceccherini-Silberstein F, van Laethem K, Li G, Vandamme AM, Rockstroh JK. Impact of HCV genotype on treatment regimens and drug resistance: A snapshot in time. Rev Med Virol. 2016;26:408-34. https://doi.org/10.1002/rmv.1895

Asselah T, Boyer N, Saadoun D, Martinot-Peignoux M, Marcellin P. Direct-acting antivirals for the treatment of hepatitis C virus infection: Optimizing current IFNfree treatment and future perspectives. Liver Int. 2016;36 (Suppl.1):47-57. https://doi.org/ 10.1111/liv.13027

Jiménez-Pérez M, González-Grande R, España Contreras P, Pinazo Martínez I, de la Cruz Lombardo J, Olmedo Martín R. Treatment of chronic hepatitis C with direct-acting antivirals: The role of resistance. World J Gastroenterol. 2016;22:6573-81. https://doi.org/10.3748/wjg.v22.i29.6573

Foster GR, Afdhal N, Roberts SK, Brau N, Gane EJ, Pianko S. Sofosbuvir and Velpatasvir for HCV genotype 2 and 3 infection. N Engl J Med. 2015;373:2608-17. https://doi.org/10.1056/NEJMoa1512612

Welzel TM, Bhardwaj N, Hedskog C, Chodavarapu K, Camus G, McNally J, et al. Global epidemiology of HCV subtypes and resistance-associated substitutions evaluated by sequencing-based subtype analyses. J Hepatol. 2017;67:224-36. https://doi.org/10.1016/j.jhep.2017.03.014

Verbeeck J, Stanley MJ, Shieh J, Celis L, Huyck E, Wollants E, et al. Evaluation of Versant hepatitis C virus genotype assay (LiPA) 2.0. J Clin Microbiol. 2008;46:1901-6. https://doi.org/10.1128/JCM.02390-07

Viera AJ, Garrett JM. Understanding interobserver agreement: The kappa statistic. Fam Med. 2005;37:360-3.

Laperche S, Lunel F, Izopet J, Alain S, Dény P, Duverlie G, et al. Comparison of hepatitis C virus NS5B and 5’ noncoding gene sequencing methods in a multicenter study. J Clin Microbiol. 2005;43:733-9. https://doi.org/10.1128/JCM.43.2.733-739.2005

Scott JD, Gretch DR. Molecular diagnostics of hepatitis C virus infection: A systematic review. JAMA. 2007;297:724-32. https://doi.org/10.1001/jama.297.7.724

Baclig MO, Chan VF, Ramos JD, Gopez-Cervantes J, Natividad FF. Correlation of the 5’untranslated region (5’UTR) and non-structural 5B (NS5B) nucleotide sequences in hepatitis C virus subtyping. Int J Mol Epidemiol Genet. 2010;1:236-44.

Martró E, González V, Buckton AJ, Saludes V, Fernández G, Matas L, et al. Evaluation of a new assay in comparison with reverse hybridization and sequencing methods for hepatitis C virus genotyping targeting both 5’ noncoding and nonstructural 5b genomic regions. J Clin Microbiol. 2008;46:192-7. https://doi.org/10.1128/JCM.01623-07

Cai Q, Zhao Z, Liu Y, Shao X, Gao Z. Comparison of three different HCV genotyping methods: Core, NS5B sequence analysis and line probe assay. Int J Mol Med. 2013;31:347-52. https://doi.org/10.3892/ijmm.2012.1209

Margall N, March F, Español M, Torras X, Gallego A, Coll P. Two unusual hepatitis C virus subtypes, 2j and 2q, in Spain: Identification by nested-PCR and sequencing of a NS5B region. J Virol Methods. 2015;223:105-8. https://doi.org/10.1016/j.jviromet.2015.07.022

del Pino N, Oubiña JR, Rodríguez-Frías F, Esteban JI, Buti M, Otero T, et al. Molecular epidemiology and putative origin of hepatitis C virus in random volunteers from Argentina. World J Gastroenterol. 2013;19:5813-27. https://doi.org/10.3748/wjg.v19.i35.5813

Sulbarán MZ, Montaño L, Sulbarán Y, Loureiro CL, Flores CR, Farías Y, et al. Caracterización molecular del virus de la hepatitis C en pacientes remitidos al Laboratorio Regional de Salud Pública del Hospital Universitario “Antonio Patricio de Alcalá”, Cumaná, Venezuela. Invest Clin. 2016:57:13-24.

Jaspe RC, Sulbarán YF, Loureiro CL, Martínez N, Devesa M, Rodríguez Y et al. Genetic diversity of hepatitis B virus and hepatitis C virus in human immunodeficiency virus type 1-co-infected patients from Venezuela. J Med Microbiol. 2014:63:1099-104. https://doi.org/10.1099/jmm.0.067496-0

Chevaliez S, Bouvier-Alias M, Brillet R, Pawlotsky JM. Hepatitis C virus (HCV) genotype 1 subtype identification in new HCV drug development and future clinical practice. PLoS One. 2009;4:1-9. https://doi.org/10.1371/journal.pone.0008209

Le Guillou-Guillemette H, Vallet S, Gaudy-Graffin C, Payan C, Pivert A, Goudeau A, et al. Genetic diversity of the hepatitis C virus: Impact and issues in the antiviral therapy. World J Gastroenterol. 2007;13:2426. https://doi.org/10.3748/wjg.v13.i17.2416

How to Cite
1.
D’Angelo P, Jaspe RC, Loureiro CL, Gutiérrez C, Sulbarán MZ, Sulbarán Y, et al. Performance of molecular methods for identification of unusual subtypes of hepatitis C virus genotype 2. biomedica [Internet]. 2018 Jun. 15 [cited 2024 May 18];38(2):282-8. Available from: https://revistabiomedica.org/index.php/biomedica/article/view/3864

Some similar items:

Published
2018-06-15
Section
Short communication

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
Crossref Cited-by logo
QR Code